{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:37:42Z","timestamp":1784810262625,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s13760-025-02863-3","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:10:41Z","timestamp":1754889041000},"page":"109-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cerebral tumefactive demyelinating lesions: clinical spectrum, long-term outcomes, and treatment"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-1835","authenticated-orcid":false,"given":"\u00d6zg\u00fc","family":"Kizek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5673-3014","authenticated-orcid":false,"given":"Ahmed Serkan","family":"Emekli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-0908","authenticated-orcid":false,"given":"Tuncay","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3286-2652","authenticated-orcid":false,"given":"Murat","family":"K\u00fcrt\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5175-0424","authenticated-orcid":false,"given":"Mefkure","family":"Eraksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"7","key":"2863_CR1","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awn098","volume":"131","author":"CF Lucchinetti","year":"2008","unstructured":"Lucchinetti CF, Gavrilova R, Metz I, Parisi JE, Scheithauer BW, Weigand S et al (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131(7):1759\u20131775","journal-title":"Brain"},{"key":"2863_CR2","doi-asserted-by":"publisher","first-page":"e1418","DOI":"10.1212\/wnl.0000000000206820","volume":"100","author":"L Cacciaguerra","year":"2023","unstructured":"Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P et al (2023) Tumefactive demyelination in MOG Ab-associated disease, multiple sclerosis, and AQP-4-IgG-positive neuromyelitis optica spectrum disorder. Neurology 100:e1418\u2013e1432. https:\/\/doi.org\/10.1212\/wnl.0000000000206820","journal-title":"Neurology"},{"key":"2863_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1474-4422(16)30043-6","volume":"15","author":"TA Hardy","year":"2016","unstructured":"Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG (2016) Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol 15:967\u2013981","journal-title":"Lancet Neurol"},{"key":"2863_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2017.08.005","volume":"381","author":"P S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez P, Meca-Lallana V, Barbosa A, Manzanares R, Palm\u00ed I, Vivancos J (2017) Tumefactive demyelinating lesions of 15 patients: clinico-radiological features, management and review of the literature. J Neurol Sci 381:32\u201338","journal-title":"J Neurol Sci"},{"key":"2863_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.msard.2017.04.003","volume":"14","author":"H Algahtani","year":"2017","unstructured":"Algahtani H, Shirah B, Alassiri A (2017) Tumefactive demyelinating lesions: a comprehensive review. Mult Scler Relat Disord 14:72\u201379","journal-title":"Mult Scler Relat Disord"},{"key":"2863_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.410330105","volume":"33","author":"JJ Kepes","year":"1993","unstructured":"Kepes JJ (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Annals Neurology: Official J Am Neurol Association Child Neurol Soc 33:18\u201327","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"key":"2863_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jns.2015.08.034","volume":"358","author":"IH Jeong","year":"2015","unstructured":"Jeong IH, Kim S-H, Hyun J-W, Joung A, Cho H-J, Kim HJ (2015) Tumefactive demyelinating lesions as a first clinical event: clinical, imaging, and follow-up observations. J Neurol Sci 358:118\u2013124","journal-title":"J Neurol Sci"},{"key":"2863_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/BF00626098","volume":"38","author":"A Dagher","year":"1996","unstructured":"Dagher A, Smirniotopoulos J (1996) Tumefactive demyelinating lesions. Neuroradiology 38:560\u2013565","journal-title":"Neuroradiology"},{"key":"2863_CR9","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3174\/ajnr.A5775","volume":"39","author":"C Suh","year":"2018","unstructured":"Suh C, Kim H, Jung S, Choi C, Kim S (2018) MRI findings in tumefactive demyelinating lesions: a systematic review and meta-analysis. Am J Neuroradiol 39:1643\u20131649","journal-title":"Am J Neuroradiol"},{"key":"2863_CR10","doi-asserted-by":"publisher","first-page":"175628642110065","DOI":"10.1177\/17562864211006503","volume":"14","author":"AG Vakrakou","year":"2021","unstructured":"Vakrakou AG, Tzanetakos D, Evangelopoulos M-E, Argyrakos T, Tzartos JS, Anagnostouli M et al (2021) Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases. Ther Adv Neurol Disord 14:17562864211006503","journal-title":"Ther Adv Neurol Disord"},{"key":"2863_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/ene.14672","volume":"28","author":"M Di Gregorio","year":"2021","unstructured":"Di Gregorio M, Torri Clerici VLA, Fenu G, Gaetani L, Gallo A, Cavalla P et al (2021) Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study. Eur J Neurol 28:1299\u20131307","journal-title":"Eur J Neurol"},{"key":"2863_CR12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/acn3.51844","volume":"10","author":"M Fereidan-Esfahani","year":"2023","unstructured":"Fereidan-Esfahani M, Decker PA, Weigand SD, Lopez Chiriboga AS, Flanagan EP, Tillema JM et al (2023) Defining the natural history of tumefactive demyelination: a retrospective cohort of 257 patients. Ann Clin Transl Neurol 10:1544\u20131555","journal-title":"Ann Clin Transl Neurol"},{"key":"2863_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578299","volume":"388","author":"K Galetta","year":"2024","unstructured":"Galetta K, Ham AS, Vishnevetsky A, Bhattacharyya S, Mateen FJ (2024) Disease modifying therapy in the treatment of tumefactive multiple sclerosis: a retrospective cohort study. J Neuroimmunol 388:578299","journal-title":"J Neuroimmunol"},{"key":"2863_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"2863_CR15","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/s41598-024-52048-w","volume":"14","author":"T Ongphichetmetha","year":"2024","unstructured":"Ongphichetmetha T, Aungsumart S, Siritho S, Apiwattanakul M, Tanboon J, Rattanathamsakul N et al (2024) Tumefactive demyelinating lesions: a retrospective cohort study in Thailand. Sci Rep 14:1426","journal-title":"Sci Rep"},{"key":"2863_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.clineuro.2017.09.013","volume":"162","author":"RS Jain","year":"2017","unstructured":"Jain RS, Khan I, Kandelwal K, Desai T (2017) Tumefactive demyelinating lesions (TDLs): a case series of clinicoradiological features. Clin Neurol Neurosurg 162:91\u201394","journal-title":"Clin Neurol Neurosurg"},{"key":"2863_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4274\/npa.y6304","volume":"51","author":"E Ekizo\u011flu","year":"2014","unstructured":"Ekizo\u011flu E, Topalo\u011flu PT, Yapici Z, Eraksoy M (2014) Inflammatory demyelinating diseases of childhood: case report and literature review. Noro Psikiyatr Ars 51:74","journal-title":"Noro Psikiyatr Ars"},{"key":"2863_CR18","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1093\/brain\/123.12.2407","volume":"123","author":"C De Dale Rd","year":"2000","unstructured":"De Dale Rd C, Chong W, Cox T, Harding B, Neville B (2000) Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 123:2407\u20132422","journal-title":"Brain"},{"key":"2863_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejpn.2025.03.005","volume":"55","author":"A Selek","year":"2025","unstructured":"Selek A, G\u00f6cmen R, G\u00fcnbey C, Konu\u015fkan B, Oncel I, Anlar B (2025) Tumefactive demyelinating lesions in children. Eur J Pediatr Neurol 55:33\u201337","journal-title":"Eur J Pediatr Neurol"},{"key":"2863_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s13760-013-0210-x","volume":"113","author":"H Durmus","year":"2013","unstructured":"Durmus H, Kurtuncu M, Tuzun E, Pehlivan M, Akman-Demir G, Yap\u0131c\u0131 Z, Eraksoy M (2013) Comparative clinical characteristics of early-and adult-onset multiple sclerosis patients with seizures. Acta Neurol Belg 113:421\u2013426","journal-title":"Acta Neurol Belg"},{"key":"2863_CR21","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1177\/1352458512438237","volume":"18","author":"A Altintas","year":"2012","unstructured":"Altintas A, Petek B, Isik N, Terzi M, Bolukbasi F, Tavsanli M et al (2012) Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study. Mult Scler J 18:1448\u20131453","journal-title":"Mult Scler J"},{"key":"2863_CR22","first-page":"728","volume":"23","author":"AK Kilic","year":"2013","unstructured":"Kilic AK, Kurne AT, Oguz KK, Soylemezoglu F, Karabudak R (2013) Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center. Turk Neurosurg 23:728\u2013735","journal-title":"Turk Neurosurg"},{"key":"2863_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105408","volume":"82","author":"I Pervin","year":"2024","unstructured":"Pervin I, Ramanathan S, Cappelen-Smith C, Vucic S, Reddel SW, Hardy TA (2024) Clinical and radiological characteristics and outcomes of patients with recurrent or relapsing tumefactive demyelination. Mult Scler Relat Disord 82:105408","journal-title":"Mult Scler Relat Disord"},{"key":"2863_CR24","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1212\/WNL.54.7.1427","volume":"54","author":"JC Masdeu","year":"2000","unstructured":"Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P (2000) Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 54:1427\u20131433","journal-title":"Neurology"},{"key":"2863_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1212\/WNL.51.3.765","volume":"51","author":"O Kantarci","year":"1998","unstructured":"Kantarci O, Siva A, Eraksoy M, Karabudak R, Sutlas N, Agaoglu J et al (1998) Survival and predictors of disability in Turkish MS patients. Neurology 51:765\u2013772","journal-title":"Neurology"},{"key":"2863_CR26","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awq118","volume":"133","author":"A Scalfari","year":"2010","unstructured":"Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, Ebers GC (2010) The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability. Brain 133:1914\u20131929","journal-title":"Brain"},{"key":"2863_CR27","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1177\/13524585241273005","volume":"30","author":"P Perini","year":"2024","unstructured":"Perini P, Gaggiola M, Rinaldi F, Gallo P, Puthenparampil M (2024) Relapsing tumefactive demyelination lesions: a unique, distinct inflammatory brain pathology. Mult Scler J 30:1835\u20131838","journal-title":"Mult Scler J"},{"key":"2863_CR28","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1177\/13524585241273075","volume":"30","author":"TA Hardy","year":"2024","unstructured":"Hardy TA, Weinshenker BG (2024) Relapsing tumefactive demyelination: time to recognize a distinct demyelinating condition? Mult Scler J 30:1838\u20131839","journal-title":"Mult Scler J"},{"key":"2863_CR29","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.59.7.1006","volume":"59","author":"A Boiko","year":"2002","unstructured":"Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D (2002) Early onset multiple sclerosis: a longitudinal study. Neurology 59:1006\u20131010","journal-title":"Neurology"},{"key":"2863_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/brain\/awl007","volume":"129","author":"C Confavreux","year":"2006","unstructured":"Confavreux C, Vukusic S (2006) Natural history of multiple sclerosis: a unifying concept. Brain 129:606\u2013616","journal-title":"Brain"},{"key":"2863_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ncl.2004.10.002","volume":"23","author":"OH Kantarci","year":"2005","unstructured":"Kantarci OH, Weinshenker BG (2005) Natural history of multiple sclerosis. Neurol Clin 23:17\u201338","journal-title":"Neurol Clin"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02863-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-025-02863-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02863-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:54:44Z","timestamp":1773384884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-025-02863-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2863"],"URL":"https:\/\/doi.org\/10.1007\/s13760-025-02863-3","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.\u00a0M.K. received honoraria, travel support, and research funds from Alexion, Merck, Novartis, Sanofi, Roche, Teva, Gen \u0130la\u00e7, Abdi \u0130brahim, Sanovel, and ARIS; served on advisory boards for these companies, and received research funds from The Scientific and Research Council of T\u00fcrkiye and Neuroimmunological Society.\u00a0A.S.E.: received travel support from Roche and Merck; received research funds from Neuroimmunological Society.\u00a0T.G. received honoraria, travel support, and research funds from Alexion, Merck, Novartis, Sanofi, Roche, Teva, Gen \u0130la\u00e7, Abdi \u0130brahim, Sanovel, and ARIS; served on advisory boards for these companies, and received research funds from The Neuroimmunological Society. O.K.: received travel support from Gen \u0130la\u00e7.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, the authors used ChatGPT-4o to assist with the rephrasing of complex scientific content for enhanced clarity and readability. After using this tool\/service, the authors reviewed and edited the content as needed and took full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}]}}